Ketorolac Administration Attenuates Retinal Ganglion Cell Death After Axonal Injury | Zendy

Francisco M. NadalNicolás | Zendy; Esther Rodríguez-Villagra | Zendy; Irene BravoOsuna | Zendy; Paloma SobradoCalvo | Zendy; Irene T. MolinaMartínez | Zendy; María Paz VillegasPérez | Zendy; Manuel VidalSanz | Zendy; Marta AgudoBarriuso | Zendy; Rocío HerreroVanrell | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ketorolac Administration Attenuates Retinal Ganglion Cell Death After Axonal Injury

Author(s) -

Francisco M. NadalNicolás,

Esther Rodríguez-Villagra,

Irene BravoOsuna,

Paloma SobradoCalvo,

Irene T. MolinaMartínez,

María Paz VillegasPérez,

Manuel VidalSanz,

Marta AgudoBarriuso,

Rocío HerreroVanrell

Publication year - 2016

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.15-18213

Subject(s) - ketorolac , ketorolac tromethamine , intravitreal administration , pharmacology , medicine , anesthesia , retinal ganglion cell , ganglion cell layer , chemistry , retinal , ophthalmology , analgesic

To assess the neuroprotective effects of ketorolac administration, in solution or delivered from biodegradable microspheres, on the survival of axotomized retinal ganglion cells (RGCs).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research